<DOC>
	<DOCNO>NCT01441284</DOCNO>
	<brief_summary>Aim study perform double-blind , crossover , placebo-controlled multicenter study evaluate efficacy pramipexole essential tremor .</brief_summary>
	<brief_title>Efficacy Pramipexole Extended Release Treatment Essential Tremor</brief_title>
	<detailed_description>Essential tremor one common movement disorder prevalence 3-5 % among elderly population . Although main clinical feature bilateral , predominantly postural-kinetic tremor , new study suggest ET spectrum clinical feature motor nonmotor element homogeneously distribute . Despite high occurrence , pharmacological treatment ET limit . Although mainline drug , propranolol primidone , provide good clinical benefit portion case , &gt; 50 % patient stop medication due inefficacy side-effects . Hypotension , dizziness , bradycardia , cognitive impairment , fatigue erectile dysfunction common side-effects contribute medication discontinuation . In open-label pilot study , investigator previously demonstrate 2.1 mg/day pramipexole extended-release improved severity tremor ( 52 % ) health-related quality life . The present study aim confirm hypothesis double-blind , crossover , placebo-controlled multicenter study .</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Diagnosis ET unambiguous base clinical diagnostic criterion . Tremor severe enough produce disability . Patients must sign write informed consent accord approval Regional Ethical Board University PÃ©cs Exclusion criterion establish accordance guideline Elble et al3 . Presence medical condition capable produce tremor ( e.g . hyperthyroidism , drug withdrawal , neuropathy , etc. ) . Except cogwheel phenomenon , presence abnormal neurological sign ( e.g . dystonia , myoclonus , ataxia , parkinsonism , cerebellar pyramidal sign , etc . ) Atypical tremor appearance ET ( e.g . isolated vocalcord tremor , orthostatic tremor , taskspecific tremor , etc . ) Presence suspicion psychogenic tremor Usage medication capable produce tremor ( e.g . sympathomimetics , valproate , etc . ) Concomitant administration drug potentially capable improve ET ( e.g . antiepileptic , betareceptor blocker ) . Previous neurosurgical treatment ( e.g . deep brain stimulation thalamotomy ) . Presence serious concomitant disorder capable interfere study ( e.g . heart failure , tumorous disorder , etc . ) Presence contraindication pramipexole treatment ( e.g . impulsive control disorder , know hypersensitivity component tablet , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pramipexole</keyword>
	<keyword>essential tremor</keyword>
	<keyword>cross-over</keyword>
</DOC>